Unknown

Dataset Information

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives.


ABSTRACT: The recent developments in immuno-oncology have opened an unprecedented avenue for the emergence of vaccine strategies. Therapeutic DNA cancer vaccines are now considered a very promising strategy to activate the immune system against cancer. In the past, several clinical trials using plasmid DNA vaccines demonstrated a good safety profile and the activation of a broad and specific immune response. However, these vaccines often demonstrated only modest therapeutic effects in clinical trials due to the immunosuppressive mechanisms developed by the tumor. To enhance the vaccine-induced immune response and the treatment efficacy, DNA vaccines could be improved by using two different strategies. The first is to increase their immunogenicity by selecting and optimizing the best antigen(s) to be

SUBMITTER: Lopes A 

PROVIDER: S-EPMC6449928 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature